+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antihistamine Drugs Market by Drug Type, Route Of Administration, Diseases Treated, End User, Formulation - Global Forecast 2025-2030- Product Image
Antihistamine Drugs Market by Drug Type, Route Of Administration, Diseases Treated, End User, Formulation - Global Forecast 2025-2030- Product Image
Sale

Antihistamine Drugs Market by Drug Type, Route Of Administration, Diseases Treated, End User, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015086
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antihistamine Drugs Market grew from USD 265.34 million in 2023 to USD 279.74 million in 2024. It is expected to continue growing at a CAGR of 5.31%, reaching USD 381.39 million by 2030.

Antihistamine drugs are primarily utilized to alleviate allergic reactions by blocking histamine's effects in the body, which makes them essential in treating conditions such as allergic rhinitis, urticaria, and anaphylaxis. The scope of the antihistamine market extends from over-the-counter solutions to prescription medications, catering to various age groups and types of allergies. Their application spans numerous sectors, including healthcare providers, pharmacies, and even home-based treatments, driven by the rise in allergy prevalence and the increasing awareness of allergy management. The end-use scope predominantly includes individual consumers seeking relief from allergies, alongside hospitals and clinics contributing to their widespread adoption. Key growth factors influencing the market include the rising incidence of allergies due to environmental pollution, a growing geriatric population susceptible to allergies, and innovations in drug formulation offering long-term relief with fewer side effects. Potential opportunities exist for market players in expanding OTC offerings, developing non-sedative antihistamines to minimize side effects, and advancing personalized medicine based on genetic understanding of allergies. However, limitations such as market saturation in developed regions, side effects like drowsiness affecting patient compliance, and competition from alternative treatments pose challenges. Additionally, stringent regulations around drug approval can slow the introduction of innovative products. For businesses, innovation could focus on enhancing the efficacy and safety profiles of medications, incorporating digital health technologies to monitor and manage allergic reactions more effectively, and exploring natural antihistamine alternatives. The market is increasingly competitive, characterized by major pharmaceutical players actively acquiring start-ups and engaging in strategic partnerships to strengthen their portfolios. Sustained growth will depend on addressing the unmet needs in the allergy treatment landscape, enabling market players to pivot towards developing comprehensive solutions that offer holistic allergy management rather than mere symptom relief.

Understanding Market Dynamics in the Antihistamine Drugs Market

The Antihistamine Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of allergic diseases and conditions worldwide boosting the demand for antihistamine drugs
    • Increasing awareness and proactive management of allergies among patients contributing to market growth
    • Growing over-the-counter availability and accessibility of antihistamine medications enhancing consumer purchase ease
  • Market Restraints
    • Price sensitivity and reimbursement issues affecting sales of prescription antihistamines
  • Market Opportunities
    • Increasing partnerships with healthcare providers and allergy specialists
    • Developing pediatric-friendly antihistamine drugs to capture the growing children’s allergy market
  • Market Challenges
    • Rising popularity and preference for alternative therapies over antihistamine drugs

Exploring Porter’s Five Forces for the Antihistamine Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Antihistamine Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antihistamine Drugs Market

External macro-environmental factors deeply influence the performance of the Antihistamine Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antihistamine Drugs Market

The Antihistamine Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antihistamine Drugs Market

The Antihistamine Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antihistamine Drugs Market

The Antihistamine Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antihistamine Drugs Market, highlighting leading vendors and their innovative profiles. These include Alcon Inc., Astellas Pharma Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim, Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Meda AB, Merck Group, Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., and UCB S.A..

Market Segmentation & Coverage

This research report categorizes the Antihistamine Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug Type
    • First-Generation H1-Antihistamines
      • Alkylamines
      • Ethanolamines
      • Ethylenediamines
      • Phenothiazines
    • H2-Antihistamines
      • Cimetidine
      • Famotidine
      • Nizatidine
      • Ranitidine
    • Nasally Administered Antihistamines
      • Levocabastine
      • Olopatadine
    • Second-Generation H1-Antihistamines
      • Acrivastine
      • Cetirizine
    • Topical H1-Antihistamines
      • Azelastine
      • Olopatadine
  • Route Of Administration
    • Nasal Administration
      • Drops
      • Sprays
    • Oral Administration
      • Capsules
      • Syrups
      • Tablets
    • Topical Administration
      • Creams
      • Gels
  • Diseases Treated
    • Allergic Rhinitis
      • Perennial Allergic Rhinitis
      • Seasonal Allergic Rhinitis
    • Chronic Urticaria
  • End User
    • Clinics
    • Home Care
    • Hospitals
  • Formulation
    • Liquid Formulations
      • Syrups
    • Solid Formulations
      • Capsules
      • Tablets
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of allergic diseases and conditions worldwide boosting the demand for antihistamine drugs
5.1.1.2. Increasing awareness and proactive management of allergies among patients contributing to market growth
5.1.1.3. Growing over-the-counter availability and accessibility of antihistamine medications enhancing consumer purchase ease
5.1.2. Restraints
5.1.2.1. Price sensitivity and reimbursement issues affecting sales of prescription antihistamines
5.1.3. Opportunities
5.1.3.1. Increasing partnerships with healthcare providers and allergy specialists
5.1.3.2. Developing pediatric-friendly antihistamine drugs to capture the growing children’s allergy market
5.1.4. Challenges
5.1.4.1. Rising popularity and preference for alternative therapies over antihistamine drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Antihistamine Drugs Market, by Drug Type
6.1. Introduction
6.2. First-Generation H1-Antihistamines
6.2.1. Alkylamines
6.2.2. Ethanolamines
6.2.3. Ethylenediamines
6.2.4. Phenothiazines
6.3. H2-Antihistamines
6.3.1. Cimetidine
6.3.2. Famotidine
6.3.3. Nizatidine
6.3.4. Ranitidine
6.4. Nasally Administered Antihistamines
6.4.1. Levocabastine
6.4.2. Olopatadine
6.5. Second-Generation H1-Antihistamines
6.5.1. Acrivastine
6.5.2. Cetirizine
6.6. Topical H1-Antihistamines
6.6.1. Azelastine
6.6.2. Olopatadine
7. Antihistamine Drugs Market, by Route Of Administration
7.1. Introduction
7.2. Nasal Administration
7.2.1. Drops
7.2.2. Sprays
7.3. Oral Administration
7.3.1. Capsules
7.3.2. Syrups
7.3.3. Tablets
7.4. Topical Administration
7.4.1. Creams
7.4.2. Gels
8. Antihistamine Drugs Market, by Diseases Treated
8.1. Introduction
8.2. Allergic Rhinitis
8.2.1. Perennial Allergic Rhinitis
8.2.2. Seasonal Allergic Rhinitis
8.3. Chronic Urticaria
9. Antihistamine Drugs Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
10. Antihistamine Drugs Market, by Formulation
10.1. Introduction
10.2. Liquid Formulations
10.2.1. Syrups
10.3. Solid Formulations
10.3.1. Capsules
10.3.2. Tablets
11. Americas Antihistamine Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Antihistamine Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Antihistamine Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ANTIHISTAMINE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTIHISTAMINE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ANTIHISTAMINE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. ANTIHISTAMINE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANTIHISTAMINE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIHISTAMINE DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALKYLAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ETHANOLAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ETHYLENEDIAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PHENOTHIAZINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RANITIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LEVOCABASTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OLOPATADINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ACRIVASTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CETIRIZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY AZELASTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OLOPATADINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHRONIC URTICARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 114. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 115. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 116. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 117. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 118. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 119. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 124. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 125. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 128. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 195. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 197. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 198. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 199. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 200. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 201. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 206. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 207. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 210. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 213. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 214. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 215. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 216. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 217. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 222. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 223. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 226. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 244. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 245. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 246. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 247. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 248. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 249. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 254. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 295. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 296. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY H2-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASALLY ADMINISTERED ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND-GENERATION H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL H1-ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISEASES TREATED, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID F

Companies Mentioned

The leading players in the Antihistamine Drugs Market, which are profiled in this report, include:
  • Alcon Inc.
  • Astellas Pharma Inc.
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Meda AB
  • Merck Group
  • Mylan N.V.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 279.74 Million
Forecasted Market Value ( USD ) by 2030 $ 381.39 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Antihistamine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Antihistamine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Food Allergy Treatment Market Size, Share & Trends Analysis Report by Allergen Type (Dairy Products, Peanuts, Poultry Product), Drug Type (Antihistamines, Decongestants), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Food Allergy Treatment Market Size, Share & Trends Analysis Report by Allergen Type (Dairy Products, Peanuts, Poultry Product), Drug Type (Antihistamines, Decongestants), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
2024 Global Forecast for Antihistamine Cold Preparations, Prescription (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Antihistamine Cold Preparations, Prescription (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.